Medtronic Terminate AF Study

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

October 1, 2024

Study Completion Date

December 31, 2026

Conditions
Persistent Atrial FibrillationLongstanding Persistent Atrial Fibrillation
Interventions
PROCEDURE

Surgical Ablation

In addition to the concomitant surgery, subjects are required to have amputation or closure (with sutures or ligation) of the left atrial appendage.The Cox Maze IV lesion set is required to be performed.

DEVICE

Cardioblate and Cryoflex hand held devices

The Cardioblate hand held devices consist of the Cardioblate iRF and Cryo surgical ablation devices.

Trial Locations (15)

15212

RECRUITING

Allegheny General Hospital, Pittsburgh

19096

COMPLETED

Lankenau Medical Center, Wynnewood

23507

COMPLETED

Sentara Norfolk General Hospital, Norfolk

43606

RECRUITING

ProMedica Toledo, Toledo

46290

RECRUITING

St Vincent Heart Center of Indiana, Indianapolis

49503

RECRUITING

Corewell Health, Grand Rapids

63110

RECRUITING

Washington University School of Medicine, St Louis

84107

RECRUITING

Intermountain Medical Center, Murray

94304

COMPLETED

Stanford Hospitals and Clinic, Palo Alto

94574

WITHDRAWN

Adventist Health St. Helena, St. Helena

98101

RECRUITING

Virginia Mason Heart Institute, Seattle

98122

RECRUITING

Swedish Medical Center, Seattle

98405

WITHDRAWN

St. Joseph Medical Center, Tacoma

06102

COMPLETED

Hartford Healthcare, Hartford

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Medtronic Cardiac Surgery

INDUSTRY

NCT03546374 - Medtronic Terminate AF Study | Biotech Hunter | Biotech Hunter